Development and first validation of the COPD Assessment Test

By P. Jones, G. Harding, P. Berry, I. Wiklund, Wen-Hung Chen, N. Leidy. European Respiratory Journal, 2009

3,242 citations recorded by the source corpus.

Subfields: Issues, ethics and legal aspects, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/e73ebb669ce4be92b04487feb11b672ba0996510

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. P. Barnes
2. R. Rodríguez-Roisín
3. C. Jenkins
4. Sonia Buist
5. Jan Zieliński
6. Yoshinosuke Fukuchi
7. S. Hurd
8. A. Anzueto

Citations in the corpus

• Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function (2016, neutral): “(%) 27/199 (14) 16/423 (4) 37/425 (9) 11/336 (3) 24/626 (4)”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Тест оценки ХОБЛ (CAT) представляет собой во просник из 8 пунктов, позволяющий сформировать чис ловой показатель, характеризующий ухудшение состоя ния здоровья пациента с ХОБЛ [124].”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Questionnaires such as the CAT (87) can be performed every 2 to 3 months; trends and changes are more valuable than single measurements.”